Financhill
Sell
50

ABVE Quote, Financials, Valuation and Earnings

Last price:
$0.51
Seasonality move :
1.44%
Day range:
$0.50 - $0.58
52-week range:
$0.34 - $13.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
64.9K
Avg. volume:
688.1K
1-year change:
-95.07%
Market cap:
$14.8M
Revenue:
$272.9M
EPS (TTM):
--
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue -- -- $158.7M $303.1M $272.9M
Revenue Growth (YoY) -- -- -- 90.96% -9.97%
 
Cost of Revenues -- -- $152.4M $304.1M $277.3M
Gross Profit -- -- $6.3M -$978.3K -$4.4M
Gross Profit Margin -- -- 3.98% -0.32% -1.6%
 
R&D Expenses -- -- $187.7K $329.3K $127.3K
Selling, General & Admin -- -- $8.6M $21.1M $22.5M
Other Inc / (Exp) -- -- $117.3K -$5.9M -$1.6M
Operating Expenses -- -- $9.4M $23.3M $24.9M
Operating Income -- -- -$3.1M -$24.2M -$29.3M
 
Net Interest Expenses -- -- $1.7M $4.1M $5.8M
EBT. Incl. Unusual Items -- -- -$4.7M -$34.2M -$36.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -$75.9K -$71.9K --
Net Income to Company -- -- -$4.6M -$34.8M -$39.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$4.6M -$34.8M -$39.5M
 
Basic EPS (Cont. Ops) -- -- -$0.18 -$1.35 -$1.53
Diluted EPS (Cont. Ops) -- -- -$0.18 -$1.35 -$1.53
Weighted Average Basic Share -- -- $25.8M $25.8M $25.8M
Weighted Average Diluted Share -- -- $25.8M $25.8M $25.8M
 
EBITDA -- -- -$1.9M -$27.9M -$28.3M
EBIT -- -- -$3M -$30.1M -$31M
 
Revenue (Reported) -- -- $158.7M $303.1M $272.9M
Operating Income (Reported) -- -- -$3.1M -$24.2M -$29.3M
Operating Income (Adjusted) -- -- -$3M -$30.1M -$31M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue -- -- -- $91.7M $70.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $91.7M $73.3M
Gross Profit -- -- -- $37.3K -$3.2M
Gross Profit Margin -- -- -- 0.04% -4.52%
 
R&D Expenses -- -- -- $78.8K $30.5K
Selling, General & Admin -- -- -- $6.1M $7.4M
Other Inc / (Exp) -- -- -- -$19.9K -$1.2M
Operating Expenses -- -- -- $6.8M $8.2M
Operating Income -- -- -- -$6.8M -$11.4M
 
Net Interest Expenses -- -- -- $1.3M $1.6M
EBT. Incl. Unusual Items -- -- -- -$8.1M -$14.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$58.3K --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$8.2M -$16.8M
 
Basic EPS (Cont. Ops) -- -- -- -$0.32 -$0.65
Diluted EPS (Cont. Ops) -- -- -- -$0.32 -$0.65
Weighted Average Basic Share -- -- -- $25.8M $25.8M
Weighted Average Diluted Share -- -- -- $25.8M $25.8M
 
EBITDA -- -- -- -$6M -$11.8M
EBIT -- -- -- -$6.7M -$12.6M
 
Revenue (Reported) -- -- -- $91.7M $70.1M
Operating Income (Reported) -- -- -- -$6.8M -$11.4M
Operating Income (Adjusted) -- -- -- -$6.7M -$12.6M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -$19.9K -$1.2M
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $1.3M $3M
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue -- -- -- $91.7M $70.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $91.7M $73.3M
Gross Profit -- -- -- $37.3K -$3.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $78.8K $30.5K
Selling, General & Admin -- -- -- $6.1M $7.4M
Other Inc / (Exp) -- -- -- -$19.9K -$1.2M
Operating Expenses -- -- -- $6.8M $8.2M
Operating Income -- -- -- -$6.8M -$11.4M
 
Net Interest Expenses -- -- -- $1.3M $1.6M
EBT. Incl. Unusual Items -- -- -- -$8.1M -$14.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$58.3K --
Net Income to Company -- -- -- -$25.9M -$22.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$8.2M -$16.8M
 
Basic EPS (Cont. Ops) -- -- -- -$0.32 -$0.65
Diluted EPS (Cont. Ops) -- -- -- -$0.32 -$0.65
Weighted Average Basic Share -- -- -- $25.8M $25.8M
Weighted Average Diluted Share -- -- -- $25.8M $25.8M
 
EBITDA -- -- -- -$6M -$11.8M
EBIT -- -- -- -$6.7M -$12.6M
 
Revenue (Reported) -- -- -- $91.7M $70.1M
Operating Income (Reported) -- -- -- -$6.8M -$11.4M
Operating Income (Adjusted) -- -- -- -$6.7M -$12.6M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents -- -- $1.6M $1.7M $710.5K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- $17.6M $25.2M $17.9M
Inventory -- -- $39.5M $35.8M $19.4M
Prepaid Expenses -- -- $415.3K $1.5M $915.5K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- $83.4M $76.6M $51.1M
 
Property Plant And Equipment -- -- $43.8M $48.2M $48.9M
Long-Term Investments -- -- $3.2M $7.1M $4.4M
Goodwill -- -- $2M -- $650K
Other Intangibles -- -- $440.5K $2.2M $1.8M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- $134.3M $135.1M $107.4M
 
Accounts Payable -- -- $27.3M $35.4M $39.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- $555.3K $17.4M $23M
Current Portion Of Capital Lease Obligations -- -- $1.3M $1.5M $1.8M
Other Current Liabilities -- -- $6.9M $3.1M $3.4M
Total Current Liabilities -- -- $78.7M $105.5M $114.8M
 
Long-Term Debt -- -- $811.1K $431.5K $138.9K
Capital Leases -- -- -- -- --
Total Liabilities -- -- $109M $133.2M $141.9M
 
Common Stock -- -- $570 $580 $580
Other Common Equity Adj -- -- -- $35.8K $125.1K
Common Equity -- -- $25.2M $2M -$34.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- $25.2M $2M -$34.5M
 
Total Liabilities and Equity -- -- $134.3M $135.1M $107.4M
Cash and Short Terms -- -- $1.6M $1.7M $710.5K
Total Debt -- -- $37.7M $57.6M $59.1M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents -- -- -- $1.7M $710.5K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $25.2M $17.9M
Inventory -- -- -- $35.8M $19.4M
Prepaid Expenses -- -- -- $1.5M $915.5K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $76.6M $51.1M
 
Property Plant And Equipment -- -- -- $48.2M $48.9M
Long-Term Investments -- -- -- $7.1M $4.4M
Goodwill -- -- -- -- $650K
Other Intangibles -- -- -- $2.2M $1.8M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $135.1M $107.4M
 
Accounts Payable -- -- -- $35.4M $39.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- $17.4M $23M
Current Portion Of Capital Lease Obligations -- -- -- $1.5M $1.8M
Other Current Liabilities -- -- -- $3.1M $3.4M
Total Current Liabilities -- -- -- $105.5M $114.8M
 
Long-Term Debt -- -- -- $431.5K $138.9K
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $133.2M $141.9M
 
Common Stock -- -- -- $580 $580
Other Common Equity Adj -- -- -- $35.8K $125.1K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $2M -$34.5M
 
Total Liabilities and Equity -- -- -- $135.1M $107.4M
Cash and Short Terms -- -- -- $1.7M $710.5K
Total Debt -- -- -- $57.6M $59.1M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders -- -- -$4.6M -$34.8M -$39.5M
Depreciation & Amoritzation -- -- $1.1M $2.3M $2.7M
Stock-Based Compensation -- -- -- $5.3M $2.3M
Change in Accounts Receivable -- -- -$7.8M -$6.6M $7.3M
Change in Inventories -- -- -$20.8M $4.2M $16.2M
Cash From Operations -- -- -$22M -$13.7M $5.3M
 
Capital Expenditures -- -- $17.7M $2.1M $2.7M
Cash Acquisitions -- -- -$3.2M -$5M -$1.2M
Cash From Investing -- -- -$24.4M -$5.1M -$3.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $24M $19.9M $9.7M
Long-Term Debt Repaid -- -- -$1.2M -$1.7M -$11M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$1.2M $852.2K -$1.6M
Cash From Financing -- -- $21.7M $19M -$3M
 
Beginning Cash (CF) -- -- $26.4M $1.6M $1.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$24.7M $207K -$1M
Ending Cash (CF) -- -- $1.6M $1.8M $705.3K
 
Levered Free Cash Flow -- -- -$39.7M -$15.7M $2.6M
Period Ending 2019-10-31 2020-10-31 2021-10-31 2022-10-31 2023-10-31
Net Income to Stockholders -- -- -- -$25.9M -$22.6M
Depreciation & Amoritzation -- -- -- $1.4M $2M
Stock-Based Compensation -- -- -- $3.8M $1.5M
Change in Accounts Receivable -- -- -- -$7.9M $4.2M
Change in Inventories -- -- -- -$5.7M $16.1M
Cash From Operations -- -- -- -$4.2M $5.3M
 
Capital Expenditures -- -- -- -- $2.4M
Cash Acquisitions -- -- -- -$211.9K -$1.2M
Cash From Investing -- -- -- -$309.7K -$3.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $8.3M $4.8M
Long-Term Debt Repaid -- -- -- -$1.1M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$5.5M -$1.6M
Cash From Financing -- -- -- $3.4M -$3.2M
 
Beginning Cash (CF) -- -- -- $1.5M $1.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$1.1M -$1.5M
Ending Cash (CF) -- -- -- $416K $191.7K
 
Levered Free Cash Flow -- -- -- -- $2.8M
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- $1.5M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- $2.4M
Cash Acquisitions -- -- -- -- -$1.2M
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2019-10-31 2020-10-31 2021-10-31 2022-10-31 2023-10-31
Net Income to Stockholders -- -- -- -$25.9M -$22.6M
Depreciation & Amoritzation -- -- -- $1.4M $2M
Stock-Based Compensation -- -- -- $3.8M $1.5M
Change in Accounts Receivable -- -- -- -$7.9M $4.2M
Change in Inventories -- -- -- -$5.7M $16.1M
Cash From Operations -- -- -- -$4.2M $5.3M
 
Capital Expenditures -- -- -- -- $2.4M
Cash Acquisitions -- -- -- -$211.9K -$1.2M
Cash From Investing -- -- -- -$309.7K -$3.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $8.3M $4.8M
Long-Term Debt Repaid -- -- -- -$1.1M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$5.5M -$1.6M
Cash From Financing -- -- -- $3.4M -$3.2M
 
Beginning Cash (CF) -- -- -- $1.5M $1.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$1.1M -$1.5M
Ending Cash (CF) -- -- -- $416K $191.7K
 
Levered Free Cash Flow -- -- -- -- $2.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock